Implementation of high‐resolution SNP arrays in the investigation of fetuses with ultrasound malformations: 5 years of clinical experience
- 3 September 2013
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 86 (3), 264-269
- https://doi.org/10.1111/cge.12271
Abstract
Chromosome microarray analysis (CMA) has proven to be a powerful tool in postnatal patients with intellectual disabilities, and it is increasingly used in prenatal diagnosis. However, its diagnostic capabilities in prenatal diagnosis vary, and clinical experiences have failed to establish a consensus regarding CMA indications, the design and resolution of microarrays, and the notification and interpretation of copy number variations (CNVs). We present our 5 years of clinical experience using whole‐genome high‐resolution single nucleotide polymorphism (SNP) arrays to investigate 446 fetuses that had structural malformations detected with ultrasound but for which standard karyotyping analysis showed normal karyotypes. CMA revealed genomic CNVs in 323 (72.4%) cases and clinically significant CNVs in 11.4% of the fetuses (51/446), including 2 cases of uniparental disomy (UPD) as well as 1 case of cryptic mosaic monosomy of chromosome X. Variants of unknown significance (VOUS) existed in 2.0% of the tested fetuses (9/446). Our results demonstrate the value of whole‐genome high‐resolution SNP arrays in fetuses with congenital malformations and give a higher detection rate of clinically significant genomic imbalance, especially for detecting UPD. Sufficient communication between technicians and genetic counselors, along with parental testing and comparison with data from in‐house or international sources, can significantly reduce VOUS.Keywords
This publication has 21 references indexed in Scilit:
- Maternal plasma sequencing: a powerful tool towards fetal whole genome recoveryBMC Medicine, 2013
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012
- Non‐targeted whole genome 250K SNP array analysis as replacement for karyotyping in fetuses with structural ultrasound anomalies: evaluation of a one‐year experiencePrenatal Diagnosis, 2012
- Genomic SNP array as a gold standard for prenatal diagnosis of foetal ultrasound abnormalitiesMolecular Cytogenetics, 2012
- Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal casesMolecular Cytogenetics, 2011
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- Array Comparative Genomic Hybridization in Prenatal Diagnosis: Another ExperienceFetal Diagnosis and Therapy, 2009
- Detection of low‐level mosaicism by array CGH in routine diagnostic specimensAmerican Journal of Medical Genetics Part A, 2006
- Risk estimates for uniparental disomy following prenatal detection of a nonhomologous Robertsonian translocationPrenatal Diagnosis, 2006
- Complex and segmental uniparental disomy (UPD): review and lessons from rare chromosomal complementsJournal of Medical Genetics, 2001